Repligen Corp
RGEN· Nasdaq
RGENRepligen Corp
Filed Aug 9, 2012 · 10-Q · 40 days after period end · 0001193125-12-346073
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Revenue | $15.52M | $7.65M | $7.01M |
| Net Income | $1.57M | -$55.00K | $988.05K |
| EPS Diluted | $0.05 | $0.00 | $0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Repligen Corp · CIK 730272 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Aug 9, 2012 · 40 d after period end
